Microglia-specific deletion of histone deacetylase 3 promotes inflammation resolution, white matter integrity, and functional recovery in a mouse model of traumatic brain injury
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background: Histone deacetylases (HDACs) are believed to exacerbate traumatic brain injury (TBI) based on studies using pan-HDAC inhibitors. However, the HDAC isoform responsible for the detrimental effects and the cell types involved remain unknown, which may hinder the development of specific targeting strategies that boost therapeutic efficacy while minimizing side effects. Microglia are important mediators of post-TBI neuroinflammation and critically impact TBI outcome. HDAC3 was reported to be essential to the inflammatory program of in vitro cultured macrophages, but its role in microglia and in the post-TBI brain has not been investigated in vivo. Methods: We generated HDAC3 LoxP mice and crossed them with CX3CR1 CreER mice, enabling in vivo conditional deletion of HDAC3. Microglia-specific HDAC3 knockout (HDAC3 miKO) was induced in CX3CR1 CreER:HDAC3 LoxP mice with 5 days of tamoxifen treatment followed by a 30-day development interval. The effects of HDAC3 miKO on microglial phenotype and neuroinflammation were examined 3–5 days after TBI induced by controlled cortical impact. Neurological deficits and the integrity of white matter were assessed for 6 weeks after TBI by neurobehavioral tests, immunohistochemistry, electron microscopy, and electrophysiology. Results: HDAC3 miKO mice harbored specific deletion of HDAC3 in microglia but not in peripheral monocytes. HDAC3 miKO reduced the number of microglia by 26%, but did not alter the inflammation level in the homeostatic brain. After TBI, proinflammatory microglial responses and brain inflammation were markedly alleviated by HDAC3 miKO, whereas the infiltration of blood immune cells was unchanged, suggesting a primary effect of HDAC3 miKO on modulating microglial phenotype. Importantly, HDAC3 miKO was sufficient to facilitate functional recovery for 6 weeks after TBI. TBI-induced injury to axons and myelin was ameliorated, and signal conduction by white matter fiber tracts was significantly enhanced in HDAC3 miKO mice. Conclusion: Using a novel microglia-specific conditional knockout mouse model, we delineated for the first time the role of microglial HDAC3 after TBI in vivo. HDAC3 miKO not only reduced proinflammatory microglial responses, but also elicited long-lasting improvement of white matter integrity and functional recovery after TBI. Microglial HDAC3 is therefore a promising therapeutic target to improve long-term outcomes after TBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A previous study reported that HDAC3-deficent microglia shift from a proinflammatory phenotype to an inflammation-resolving phenotype with a reduction of microglia number in a mouse model of TBI (10).”
From Arresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke (2024) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a mouse model of traumatic brain injury (TBI), HDAC3 knockout also drove microglial turnover from a proinflammatory phenotype to an inflammation-resolving phenotype (10).”
From Arresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke (2024) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, X., Wang, H., Zhou, M., Li, X., Fang, Z., Gao, H., Li, Y., & Hu, W. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00117 · Cited by 99
RetractedMicroglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599 · cited 3×
“Since CX3CR1 is expressed by microglia and peripheral monocytes [17], and both cells are present in the brain after TBI [29], we employed a tamoxifen pulse knockout strategy to restrict CX3CR1CreER-mediated HDAC3 knockout to microglia [17].”
BackgroundMethodHaberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526 · cited 2×
“HDACs are a superfamily of enzymes that can reduce acetylation of histones and exert transcriptional repression [1].”
BackgroundNew tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804 · cited 1×
“This limitation is being tackled with the use of emerging microglia-specific markers identified by single-cell analyses such as TMEM119 [38], and CreER mice driven by the Tmem119 promoter were recently generated [39].”
BackgroundSelf-citationM2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777 · cited 1×
“Antiinflammatory and immunomodulatory “M2” microglia/macrophages could also produce trophic factors that enhance white matter repair after injury [44].”
Microglial and macrophage polarization—new prospects for brain repair
Hu, X., Leak, R. K., Shi, Y., Suenaga, J., Gao, Y., Zheng, P., & Chen, J. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.207 · Cited by 1,366 · cited 14×
“2C): (1) resting/quiescent (expressing neither CD16/32 nor CD206); (2) proinflammatory (expressing CD16/32 but not CD206); (3) intermediate (expressing both CD16/32 and CD206); and (4) inflammation-resolving (expressing CD206 but not CD16/32).”
BackgroundSelf-citationObject recognition test in mice
Leger, M., Quiedeville, A., Bouet, V., Haelewyn, B., Boulouard, M., Schumann-Bard, P., & Freret, T. (2013) · Nature Protocols · doi:10.1038/nprot.2013.155 · Cited by 1,357 · cited 1×
“, those assessed by the novel object recognition test [45] or some paradigms of passive avoidance test [46].”
Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets
Ng, S. Y., & Lee, A. Y. W. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00528 · Cited by 852
Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention
Kumar, A., & Loane, D. J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.008 · Cited by 710 · cited 1×
“cells Microglia are important mediators of inflammatory responses in the post-TBI brain, which critically influences TBI outcomes [32, 33].”
BackgroundA new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
Goldmann, T., Wieghofer, P., Müller, P. F., Wolf, Y., Varol, D., Yona, S., Brendecke, S. M., Kierdorf, K., Staszewski, O., Datta, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3531 · Cited by 688 · cited 3×
“1C), whereas CNS microglia had a substantially lower turnover rate [17, 30].”
BackgroundMethod
Cited by
Role of histone deacetylases and their inhibitors in neurological diseases
Zhang, L.-Y., Zhang, S.-Y., Wen, R., Zhang, T.-N., & Yang, N. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107410 · Cited by 84
Tackling the glial scar in spinal cord regeneration: new discoveries and future directions
Shafqat, A., Albalkhi, I., Magableh, H. M., Saleh, T., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1180825 · Cited by 78
Wang, Y., Cai, Z., Zhan, G., Li, X., Li, S., Wang, X., Li, S., & Luo, A. (2023) · Antioxidants · doi:10.3390/antiox12030714 · Cited by 71
“To further investigate whether CAPE could modulate M1/M2 microglia polarization in the aged POCD model, we applied confocal microscopy and three-dimensional (3D) reconstitution to analyze the morphology [57] and n mber of microglia in the hippocampus.”
MethodSelf-citationArresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke
Zhang, Y., Li, J., Zhao, Y., Huang, Y., Shi, Z., Wang, H., Cao, H., Wang, C., Wang, Y., Chen, D., et al. (2024) · Science Advances · doi:10.1126/sciadv.ade6900 · Cited by 55
Self-citationHistone deacetylase 3 regulates microglial function through histone deacetylation
Meleady, L., Towriss, M., Kim, J. S., Bacarac, V., Dang, V., Rowland, M. E., & Ciernia, A. V. (2023) · Epigenetics · doi:10.1080/15592294.2023.2241008 · Cited by 47
“The increase in Hdac3 protein levels appears to confer pro-inflammatory functions [27,28] as conditional deletion of Hdac3 in microglia improves outcomes following brain injury [29] and pharmacological inhibition of Hdac3’s deacetylase activity reduces neuroinflammation and is protective in models of depression [26],…”
Background
Metadata
- Authors
- Zhao, Y., Mu, H., Huang, Y., Li, S., Wang, Y., Stetler, R. A., Bennett, M. V. L., Dixon, C. E., Chen, J., & Shi, Y.
- Affiliations
- University of Pittsburgh (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Chen, Jun
- Shi, Yejie
- ORCID
- Venue
- Journal of Neuroinflammation
- Published
- 2022-08-06
- Volume
- 19
- Issue
- 1
- Pages
- 201-201
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC9357327
- OpenAlex
- W4290068889
- Cited by
- 47
- References
- 51
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 11 · 2023: 10 · 2022: 1
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Neurological Disorders and Stroke (NS108695)
- U.S. Department of Veterans Affairs (BX005290)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Keywords
- HDAC3, microglia, traumatic brain injury, neuroinflammation, inflammation resolution, white matter integrity, axonal injury, myelin damage, functional recovery, microglial phenotype, conditional knockout mice, controlled cortical impact, therapeutic target
- MeSH terms
- Brain Injuries, Traumatic, Histone Deacetylase 3, Animals, Disease Models, Animal, Histone Deacetylases, Inflammation, Mice, Inbred C57BL, Microglia, Mice, Knockout, Mice, White Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microglia-specific deletion of histone deacetylase 3 promotes inflammation resolution, white matter integrity, and functional recovery in a mouse model of traumatic brain injury. https://app.cochat.ai/papers/10.1186/s12974-022-02563-2
- The paper
- Zhao, Y., Mu, H., Huang, Y., Li, S., Wang, Y., Stetler, R. A., Bennett, M. V. L., Dixon, C. E., Chen, J., & Shi, Y. (2022). Microglia-specific deletion of histone deacetylase 3 promotes inflammation resolution, white matter integrity, and functional recovery in a mouse model of traumatic brain injury. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-022-02563-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.